ClinicalTrials.gg
RecruitingNCT07891624Updated Oct 23, 2026

Neural Mechanisms of Real-world Emotions and Internalizing

An interventional study of Academic Performance Feedback in Major Depression, Generalized Anxiety and Emotions, sponsored by University of Miami. Recruiting at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by University of Miami · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Not applicable
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This study utilizes mobile health methods, including smartphone technology, subjective self-reports measures of emotion, behavioral tasks, functional Magnetic Resonance Imaging (fMRI), physiological measures of attention and arousal, and measures of health and social support to identify neural mechanisms associated with individual differences in the temporal course of emotional responses. The aim of this project is to utilize real-world and personally relevant events as stimuli to better understand how the temporal course of emotional responses relate to risk for developing mental disorders.

02

Conditions studied

  • Major Depression
  • Generalized Anxiety
  • Emotions
03

In context

Depressive Disorder, Major

2,805 studies on the registry are indexed under Depressive Disorder, Major; 565 are open to participants now.

This study's planned enrollment of 144 is above the median of 80 across 2,338 interventional studies indexed under Depressive Disorder, Major.

Browse Depressive Disorder, Major studies →

Lead sponsor

University of Miami is the lead sponsor of 838 studies on the registry; 164 are open to participants now.

Of its 114 completed or terminated interventional studies of FDA-regulated products, 96 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals who are between 18 - 35 years old. [Reason: to be able to provide informed consent, and to minimize variation in functional and structural differences in brain]
  • Individuals who are fluent English speakers. [Reason: to understand study instructions \& questionnaires]
  • Smart phone access. [Reason: to answer the questionnaires that are administered throughout the study.

Exclusion criteria

Exclusion Criteria:

  • Women who are pregnant or breast feeding and are no more than six months post-partum. [Reason: may be unsafe for fetus, may affect outcome measure(s)]
  • Individuals who are excluded based on attached metal resonance Screening Form (Note: this form has already been approved by the Institutional Review Board (IRB for other protocols). [Reason: necessary to participate in MRI research protocol]
  • Individuals whose BMI is above 35. [Reason: must fit into fMRI scanner]
  • Individuals who have claustrophobia. [Reason: to be able to stay in MRI scanner]
  • Individuals who are unable, in the judgment of the investigator, to comply with directions and/or tolerate the procedures required for participation in this trial. [Reason: to be able to understand instructions and ensure safety]
  • Individuals who are unable to safely undergo MRI scanning. [Reason: to be able to undergo MRI scanning]
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
144 participants (estimated)

Study arms

  • Experimental
    Participants Undergoing Academic Performance Feedback Assessments

    Participants undergo up to six study visits during one academic semester, including baseline and post-examination MRI assessments. During MRI sessions, participants anticipate and receive actual midterm examination grades while neural and physiological responses are measured. Participants also complete repeated mobile mood assessments and self-report measures throughout the semester.

    Behavioral: Academic Performance Feedback

Interventions

  • BehavioralAcademic Performance Feedback

    Participants receive personally relevant academic performance feedback (actual midterm examination grades) during fMRI assessments. During each scan session, participants undergo a period of grade anticipation followed by disclosure of their exam grade while neural activity, physiological responses, and emotional experiences are assessed. The intervention is administered during repeated MRI sessions conducted over a single academic semester.

06

What researchers measure

Primary outcomes

  1. Mean Duration of fMRI-Derived Negative Emotional Brain States

    Mean duration, measured in seconds, of fMRI-derived negative emotional brain states identified using hidden Markov modeling of default mode and salience network activity during academic performance feedback assessments.

    Time frame: Baseline and end of academic semester (approximately 17 weeks)

07

Study locations

1 of 1 sites recruiting
  • University of Miami
    Coral Gables, Florida 33146, United States
    • Aaron S Heller, PhD · Contact · axh825@miami.edu · 305-284-9498
    • Aaron Heller, PhD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The proposed research will generate data including self-report, structured interviews, and FMRI measures from young adults. Data will be publicly shared via datalad.org within 1 year after data collection is completed. Data will be linked to one another and connected to code via github. This approach is the currently recommended approach by the Center for Reproducible Neuroscience at Stanford. Code will be uploaded to the lab's github page.

Supporting information: Study protocol, Analytic code

Time frame: 1 year after study is completed

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891624
Responsible party
Aaron Heller (Professor of Psychology, University of Miami) — Principal investigator
First posted
Oct 23, 2026
Start date
Aug 24, 2026
Primary completion
Nov 30, 2030 (estimated)
Completion
Nov 30, 2030 (estimated)
Last update
Oct 23, 2026

Study contacts

Aaron S Heller, PhD
Contact
axh825@miami.edu
305-284-9498
Aaron S Heller, PhD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion